发明名称 METHOD FOR NORMALISATION OF THROMBOCYTE SENSITIVITY TO AGGREGATION INDUCERS IN PATIENTS SUFFERING FROM ARTERIAL HYPERTENSION WITH IMPAIRED GLUCOSE TOLERANCE
摘要 FIELD: medicine. ^ SUBSTANCE: invention concerns medicine, namely haematology and endocrinology, and concerns normalisation of thrombocyte sensitivity to aggregation inducers in patients suffering from arterial hypertension with impaired glucose tolerance. That is ensured by integrated therapy including graduated physical exercises, and introduction of lisinopril in a dose 10 mg once a day in the morning and pioglitazone in a dose 30 mg once a day in the morning. Therapeutic course lasts for at least 6 weeks. The method enables complete normalisation of thrombocyte sensitivity to aggregation inducers owing to potentiation of therapeutic effect of certain components of integrated therapy. ^ EFFECT: that in turn allows reducing risk of thrombotic complications in given group of patients. ^ 1 ex, 3 dwg, 2 tbl
申请公布号 RU2372909(C1) 申请公布日期 2009.11.20
申请号 RU20080128903 申请日期 2008.07.14
申请人 MEDVEDEV IL'JA NIKOLAEVICH 发明人 MEDVEDEV IL'JA NIKOLAEVICH;GAMOLINA OL'GA VLADIMIROVNA
分类号 A61H1/00;A61K31/401;A61K31/426;A61P5/50;A61P9/12 主分类号 A61H1/00
代理机构 代理人
主权项
地址